Valuation Metrics Signal Elevated Price Levels
Sanstar Ltd’s current P/E ratio is an eye-catching 84.11, a significant increase that places it in the “very expensive” category according to MarketsMOJO’s valuation grading. This is notably higher than peers such as Titan Biotech and Stallion India, which have P/E ratios of 75.35 and 37.77 respectively, both also classified as very expensive but still considerably lower than Sanstar’s multiple. The company’s price-to-book value ratio of 2.48 further underscores the premium investors are paying relative to its net asset base.
Other valuation multiples reinforce this elevated pricing. The enterprise value to EBITDA (EV/EBITDA) ratio stands at 85.30, dwarfing the sector’s more moderate levels, while the EV to EBIT ratio is an extraordinary 188.82. These figures suggest that the market is pricing in substantial growth or operational improvements that have yet to materialise in financial results.
Profitability and Returns Remain Underwhelming
Despite the lofty valuation, Sanstar’s latest return on capital employed (ROCE) is a mere 1.68%, and return on equity (ROE) is 2.95%. These low profitability metrics contrast sharply with the high multiples, indicating a disconnect between price and underlying financial performance. The absence of dividend yield further diminishes the stock’s appeal for income-focused investors.
Such a disparity often signals heightened risk, as investors may be overestimating future earnings growth or operational efficiencies. The company’s PEG ratio is reported as zero, which typically indicates either a lack of earnings growth or insufficient data, adding to the uncertainty surrounding valuation justification.
Stock Price Movement and Market Comparison
Sanstar’s share price closed at ₹90.03 on 4 May 2026, up 3.98% from the previous close of ₹86.58. The stock’s 52-week high is ₹107.25, with a low of ₹74.34, reflecting a relatively wide trading range. Over the past month, the stock has delivered a robust return of 18.99%, outperforming the Sensex’s 6.90% gain in the same period. However, year-to-date (YTD) performance remains negative at -6.41%, though still better than the Sensex’s -9.75% decline.
Longer-term returns are less encouraging, with a one-year loss of 2.14% compared to the Sensex’s 4.15% drop. Data for three, five, and ten-year returns are unavailable, limiting a comprehensive assessment of the company’s historical performance relative to the broader market.
Our current monthly pick, this Mid Cap from Automobile Two & Three Wheelers, survived rigorous evaluation against dozens of contenders. See why experts are backing this one!
- - Rigorous evaluation cleared
- - Expert-backed selection
- - Mid Cap conviction pick
Comparative Valuation: Sanstar vs Peers
When benchmarked against its industry peers, Sanstar’s valuation stands out as particularly stretched. Titan Biotech and Stallion India, both classified as very expensive, trade at P/E multiples of 75.35 and 37.77 respectively, with EV/EBITDA ratios of 61.39 and 34.83. Meanwhile, companies like Gulshan Polyols and TGV Sraac are rated very attractive, with P/E ratios of 26.45 and 8.6 and EV/EBITDA multiples of 11.66 and 3.95 respectively, highlighting a wide valuation spectrum within the sector.
Platinum Industries and Jyoti Resins fall into the expensive category but maintain more moderate multiples, with P/E ratios of 29.71 and 14.48 respectively. This peer comparison emphasises that Sanstar’s valuation is an outlier, demanding a premium that may be difficult to justify given its current financial metrics.
Market Capitalisation and Analyst Sentiment
Sanstar is classified as a micro-cap stock, which often entails higher volatility and risk due to lower liquidity and limited analyst coverage. The company’s Mojo Score currently stands at 35.0, with a Mojo Grade of Sell, upgraded from a previous Strong Sell rating on 16 January 2026. This slight improvement in sentiment suggests some stabilisation but remains cautious overall.
The upgrade in grade reflects a modest reassessment of the company’s prospects, yet the valuation grade has shifted from expensive to very expensive, signalling that price levels have outpaced fundamental improvements. Investors should weigh this divergence carefully when considering exposure to Sanstar.
Investment Implications and Outlook
Sanstar Ltd’s elevated valuation metrics, combined with subdued profitability and mixed market returns, present a complex picture for investors. The stock’s recent price appreciation and outperformance over the past month may attract momentum traders, but the stretched P/E and EV multiples raise concerns about sustainability.
Given the company’s micro-cap status and low returns on capital, investors may prefer to exercise caution and consider alternative opportunities within the sector or broader market that offer more attractive valuations and stronger fundamentals.
Holding Sanstar Ltd from Other Agricultural Products? See if there's a smarter choice! SwitchER compares it with peers and suggests superior options across market caps and sectors!
- - Peer comparison ready
- - Superior options identified
- - Cross market-cap analysis
Conclusion
Sanstar Ltd’s transition to a very expensive valuation grade amid modest financial performance and micro-cap risks suggests that investors should approach the stock with caution. While recent price gains and a slight improvement in analyst sentiment offer some optimism, the high P/E and EV multiples relative to peers and historical benchmarks indicate that the stock may be overvalued at current levels.
Investors seeking exposure to the Other Agricultural Products sector would be well advised to consider valuation alongside profitability and growth prospects, favouring companies with more balanced metrics and stronger returns on capital.
Get Started for only Rs. 16,999 - Get MojoOne for 2 Years + 1 Year Absolutely FREE! (72% Off) Start Today
